Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease
✍ Scribed by Biundo, Roberta; Weis, Luca; Pilleri, Manuela; Facchini, Silvia; Formento-Dojot, Patrizia; Vallelunga, Annamaria; Antonini, Angelo
- Book ID
- 120036909
- Publisher
- Springer
- Year
- 2013
- Tongue
- English
- Weight
- 255 KB
- Volume
- 120
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Neuropsychological deficits, such as poor episodic memory, are consistent features of mild cognitive impairment and also that of early stage of dementia. The aim of the present study was to detect cognitive dysfunction among patients with Alzheimer's disease or with mild cognitive impairment (MCI),
## Abstract ## Background The Cambridge cognitive examination (CAMCOG) is a mini neuropsychological battery which is well established and widely used. The utility of the CAMCOG in detecting prodromal Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) has not been determined.
Mild cognitive impairment (MCI) may predict future development of dementia in Parkinson's disease (PD). We aimed to examine the extent of subcortical brain atrophy in patients with early PD with and without MCI compared to normal controls (NC). Participating in a population-based study were 43 early